Albiotic, 330/100mg, Intramamární roztok
Albiotic, 330/100mg, Intramamární roztok
Authorised
- Lincomycin
- Neomycin
Product identification
Medicine name:
Albiotic, 330/100mg, Intramamární roztok
Active substance:
- Lincomycin
- Neomycin
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Lincomycin330.00milligram(s)1.00Applicator
-
Neomycin100.00milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary solution
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (lactating cow)
-
Meat and offal3day
-
Milk84hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RF03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet J.S.C.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/1406/97-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: